Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Harr

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Revue Medicale Suisse|April 3, 2024
[Antihistamines : An ongoing narrative]Sophie Vandenberghe-Dürr, Thomas Harr, Frederik Vandenberghe
Revue Medicale Suisse|February 25, 2014
[Omalizumab in the treatment of chronic urticaria: what's new in 2013?]David Spoerl, Thomas Harr, Jörg D Seebach
Revue Medicale Suisse|December 16, 2015
[Benefits of gluten-free diet: myth or reality?]Yann Coattrenec, Thomas Harr, Claude Pichard, et al.
Contact Dermatitis|March 20, 2026
Occupational Asthma and Contact Urticaria in a Wildlife Worker With Type I Hypersensitivity to Deer DanderEglė Janušonytė, Thomas Harr, Peter Jandus, et al.
Praxis|May 8, 2014
[Therapy of anaphylaxis]Martin Meyer, Dominik Schaer, Thomas Harr, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 24, 2017
Anaphylactic shock to H1 antihistamine drug bilastine: A case reportYann Coattrenec, David Spoerl, Peter Jandus, et al.
Revue Medicale Suisse|January 17, 2018
[Allergology and clinical immunology]Yann Coattrenec, Thomas Harr, Carlo Chizzolini, et al.
International Journal of Molecular Sciences|June 8, 2017
Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?David Spoerl, Haig Nigolian, Christoph Czarnetzki, et al.
BMJ Case Reports|November 29, 2024
Anaphylactic shock and cardiac arrest after intravenous injection of sulphur hexafluoride SonoVueAni Nigolian, Haïg Nigolian, Thomas Harr, et al.
Revue Medicale Suisse|April 2, 2026
[Diagnostic management of a drug allergic reaction]Sophie Frésard, Morgane Schwab, Ophélie Marchal, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Revue Medicale Suisse|April 3, 2024
[Antihistamines : An ongoing narrative]Sophie Vandenberghe-Dürr, Thomas Harr, Frederik Vandenberghe
Revue Medicale Suisse|February 25, 2014
[Omalizumab in the treatment of chronic urticaria: what's new in 2013?]David Spoerl, Thomas Harr, Jörg D Seebach
Revue Medicale Suisse|December 16, 2015
[Benefits of gluten-free diet: myth or reality?]Yann Coattrenec, Thomas Harr, Claude Pichard, et al.
Contact Dermatitis|March 20, 2026
Occupational Asthma and Contact Urticaria in a Wildlife Worker With Type I Hypersensitivity to Deer DanderEglė Janušonytė, Thomas Harr, Peter Jandus, et al.
Praxis|May 8, 2014
[Therapy of anaphylaxis]Martin Meyer, Dominik Schaer, Thomas Harr, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 24, 2017
Anaphylactic shock to H1 antihistamine drug bilastine: A case reportYann Coattrenec, David Spoerl, Peter Jandus, et al.
Revue Medicale Suisse|January 17, 2018
[Allergology and clinical immunology]Yann Coattrenec, Thomas Harr, Carlo Chizzolini, et al.
International Journal of Molecular Sciences|June 8, 2017
Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?David Spoerl, Haig Nigolian, Christoph Czarnetzki, et al.
BMJ Case Reports|November 29, 2024
Anaphylactic shock and cardiac arrest after intravenous injection of sulphur hexafluoride SonoVueAni Nigolian, Haïg Nigolian, Thomas Harr, et al.
Revue Medicale Suisse|April 2, 2026
[Diagnostic management of a drug allergic reaction]Sophie Frésard, Morgane Schwab, Ophélie Marchal, et al.
Pageof 5